Patent · US Expired

Aralkyl diazabicycloalkane derivatives for CNS disorders

US6656930B2 · kind B2 · utility

0Cited by

17References

12Claims

0Family size

Assignee

The United States of America, as represented by the Department of Health and Human Services · US

Inventors

Wayne Bowen · Derwood, US
Brian R. de Costa · Rockville, US
Celia Dominguez · Los Angeles, US
Xiao He · Branford, US
Kenner C. Rice · Bethesda, US

Key dates

Filing date	Sep 4, 2001
Grant date	Dec 2, 2003
Priority date	—
Expiry date	Sep 4, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain aralkyl diazabicycloalkyl compounds are disclosed for treatment of CNS disorders, such as cerebral ischemia, psychosis, and convulsions. For example, compounds of interest are of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.